Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer
2012 · Cancer Chemotherapy and Pharmacology · 56 citations
https://doi.org/10.1007/s00280-012-1826-x